In exercising some of his stock options last year, BioNTech CEO Uğur Şahin, M.D., scored a whopping 259.5 million euros ($281 million) in calculated compensation.
BioNTech revealed the windfall in its annual report, published March 10.
privacy policy | terms of use | contact us | advertise | pharma blogs | facebook | twitter
Copyright © 2025,